nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—GSTP1—kidney cancer	0.316	0.788	CbGaD
Clomipramine—ABCB1—kidney cancer	0.085	0.212	CbGaD
Clomipramine—HTR2B—Sorafenib—kidney cancer	0.0357	0.0987	CbGbCtD
Clomipramine—ABCB1—Temsirolimus—kidney cancer	0.0243	0.0671	CbGbCtD
Clomipramine—HTR2C—Sorafenib—kidney cancer	0.0233	0.0643	CbGbCtD
Clomipramine—CYP2D6—Temsirolimus—kidney cancer	0.0229	0.0632	CbGbCtD
Clomipramine—CYP3A4—Everolimus—kidney cancer	0.0215	0.0595	CbGbCtD
Clomipramine—ALB—Erlotinib—kidney cancer	0.0174	0.0481	CbGbCtD
Clomipramine—CYP1A2—Pazopanib—kidney cancer	0.0146	0.0403	CbGbCtD
Clomipramine—CYP3A4—Temsirolimus—kidney cancer	0.0145	0.0402	CbGbCtD
Clomipramine—ABCB1—Pazopanib—kidney cancer	0.0128	0.0352	CbGbCtD
Clomipramine—CYP2D6—Pazopanib—kidney cancer	0.012	0.0332	CbGbCtD
Clomipramine—ABCB1—Dactinomycin—kidney cancer	0.0117	0.0322	CbGbCtD
Clomipramine—CYP1A2—Erlotinib—kidney cancer	0.0104	0.0288	CbGbCtD
Clomipramine—ABCB1—Gemcitabine—kidney cancer	0.00922	0.0255	CbGbCtD
Clomipramine—CYP2C19—Sorafenib—kidney cancer	0.00917	0.0253	CbGbCtD
Clomipramine—ABCB1—Erlotinib—kidney cancer	0.0091	0.0251	CbGbCtD
Clomipramine—CYP2D6—Erlotinib—kidney cancer	0.00858	0.0237	CbGbCtD
Clomipramine—CYP1A2—Sorafenib—kidney cancer	0.00846	0.0234	CbGbCtD
Clomipramine—ABCB1—Paclitaxel—kidney cancer	0.00833	0.023	CbGbCtD
Clomipramine—CYP3A4—Pazopanib—kidney cancer	0.00764	0.0211	CbGbCtD
Clomipramine—ABCB1—Sorafenib—kidney cancer	0.0074	0.0204	CbGbCtD
Clomipramine—ABCB1—Vinblastine—kidney cancer	0.00731	0.0202	CbGbCtD
Clomipramine—ABCB1—Vincristine—kidney cancer	0.00718	0.0199	CbGbCtD
Clomipramine—CYP2D6—Sorafenib—kidney cancer	0.00697	0.0193	CbGbCtD
Clomipramine—CYP2D6—Vinblastine—kidney cancer	0.00689	0.019	CbGbCtD
Clomipramine—ABCB1—Sunitinib—kidney cancer	0.006	0.0166	CbGbCtD
Clomipramine—CYP3A4—Erlotinib—kidney cancer	0.00545	0.0151	CbGbCtD
Clomipramine—CYP3A4—Paclitaxel—kidney cancer	0.00499	0.0138	CbGbCtD
Clomipramine—ABCB1—Doxorubicin—kidney cancer	0.00449	0.0124	CbGbCtD
Clomipramine—CYP3A4—Sorafenib—kidney cancer	0.00443	0.0123	CbGbCtD
Clomipramine—CYP3A4—Vinblastine—kidney cancer	0.00438	0.0121	CbGbCtD
Clomipramine—CYP3A4—Vincristine—kidney cancer	0.0043	0.0119	CbGbCtD
Clomipramine—CYP2D6—Doxorubicin—kidney cancer	0.00423	0.0117	CbGbCtD
Clomipramine—CYP3A4—Sunitinib—kidney cancer	0.00359	0.00993	CbGbCtD
Clomipramine—GSTP1—urine—kidney cancer	0.00282	0.141	CbGeAlD
Clomipramine—CYP3A4—Doxorubicin—kidney cancer	0.00269	0.00743	CbGbCtD
Clomipramine—Olopatadine—S100A1—kidney cancer	0.00202	0.589	CrCbGaD
Clomipramine—CYP2C19—urine—kidney cancer	0.00194	0.0971	CbGeAlD
Clomipramine—CYP1A2—urine—kidney cancer	0.00159	0.0793	CbGeAlD
Clomipramine—HTR2A—urine—kidney cancer	0.00124	0.062	CbGeAlD
Clomipramine—CYP3A4—urine—kidney cancer	0.00115	0.0574	CbGeAlD
Clomipramine—CYP2D6—urine—kidney cancer	0.00113	0.0565	CbGeAlD
Clomipramine—HRH2—cardiac atrium—kidney cancer	0.000858	0.0428	CbGeAlD
Clomipramine—GSTP1—nephron tubule—kidney cancer	0.000759	0.0379	CbGeAlD
Clomipramine—GSTP1—renal system—kidney cancer	0.00069	0.0344	CbGeAlD
Clomipramine—GSTP1—kidney—kidney cancer	0.000667	0.0333	CbGeAlD
Clomipramine—GSTP1—cortex of kidney—kidney cancer	0.000649	0.0324	CbGeAlD
Clomipramine—GSTP1—gonad—kidney cancer	0.000618	0.0309	CbGeAlD
Clomipramine—GSTP1—cardiac atrium—kidney cancer	0.000618	0.0308	CbGeAlD
Clomipramine—Dimetacrine—ACHE—kidney cancer	0.000537	0.156	CrCbGaD
Clomipramine—HTR2B—cortex of kidney—kidney cancer	0.000535	0.0267	CbGeAlD
Clomipramine—SLC6A2—gonad—kidney cancer	0.000453	0.0226	CbGeAlD
Clomipramine—CYP1A2—renal system—kidney cancer	0.000388	0.0194	CbGeAlD
Clomipramine—ADRA2A—cortex of kidney—kidney cancer	0.000336	0.0168	CbGeAlD
Clomipramine—ADRA2A—gonad—kidney cancer	0.00032	0.016	CbGeAlD
Clomipramine—ADRA2A—cardiac atrium—kidney cancer	0.00032	0.016	CbGeAlD
Clomipramine—HTR2A—renal system—kidney cancer	0.000304	0.0152	CbGeAlD
Clomipramine—HTR2A—kidney—kidney cancer	0.000294	0.0147	CbGeAlD
Clomipramine—CYP3A4—renal system—kidney cancer	0.000281	0.014	CbGeAlD
Clomipramine—CYP2D6—renal system—kidney cancer	0.000277	0.0138	CbGeAlD
Clomipramine—HTR2A—gonad—kidney cancer	0.000272	0.0136	CbGeAlD
Clomipramine—CYP3A4—kidney—kidney cancer	0.000272	0.0136	CbGeAlD
Clomipramine—CYP2D6—kidney—kidney cancer	0.000267	0.0134	CbGeAlD
Clomipramine—ABCB1—nephron tubule—kidney cancer	0.000219	0.0109	CbGeAlD
Clomipramine—ABCB1—renal system—kidney cancer	0.000199	0.00994	CbGeAlD
Clomipramine—ABCB1—kidney—kidney cancer	0.000192	0.00961	CbGeAlD
Clomipramine—ABCB1—cortex of kidney—kidney cancer	0.000187	0.00936	CbGeAlD
Clomipramine—ABCB1—gonad—kidney cancer	0.000178	0.00891	CbGeAlD
Clomipramine—Triflupromazine—BCHE—kidney cancer	0.000154	0.0448	CrCbGaD
Clomipramine—Nortriptyline—PTGS1—kidney cancer	8.51e-05	0.0248	CrCbGaD
Clomipramine—Chlorpromazine—BCHE—kidney cancer	7.41e-05	0.0216	CrCbGaD
Clomipramine—Diazepam—PTGS1—kidney cancer	6.43e-05	0.0187	CrCbGaD
Clomipramine—Triflupromazine—ABCB1—kidney cancer	6.02e-05	0.0175	CrCbGaD
Clomipramine—Clobazam—ABCB1—kidney cancer	5.35e-05	0.0156	CrCbGaD
Clomipramine—Mood swings—Doxorubicin—kidney cancer	5.09e-05	0.000283	CcSEcCtD
Clomipramine—Diarrhoea—Sunitinib—kidney cancer	5.08e-05	0.000282	CcSEcCtD
Clomipramine—Ataxia—Doxorubicin—kidney cancer	5.05e-05	0.00028	CcSEcCtD
Clomipramine—Mental disorder—Capecitabine—kidney cancer	5.05e-05	0.00028	CcSEcCtD
Clomipramine—Asthenia—Dactinomycin—kidney cancer	5.04e-05	0.00028	CcSEcCtD
Clomipramine—Confusional state—Paclitaxel—kidney cancer	5.03e-05	0.000279	CcSEcCtD
Clomipramine—Malnutrition—Capecitabine—kidney cancer	5.02e-05	0.000279	CcSEcCtD
Clomipramine—Dehydration—Doxorubicin—kidney cancer	4.99e-05	0.000277	CcSEcCtD
Clomipramine—Anaphylactic shock—Paclitaxel—kidney cancer	4.99e-05	0.000277	CcSEcCtD
Clomipramine—Oedema—Paclitaxel—kidney cancer	4.99e-05	0.000277	CcSEcCtD
Clomipramine—Body temperature increased—Vincristine—kidney cancer	4.97e-05	0.000276	CcSEcCtD
Clomipramine—Abdominal pain—Vincristine—kidney cancer	4.97e-05	0.000276	CcSEcCtD
Clomipramine—Flatulence—Capecitabine—kidney cancer	4.94e-05	0.000275	CcSEcCtD
Clomipramine—Dry skin—Doxorubicin—kidney cancer	4.92e-05	0.000273	CcSEcCtD
Clomipramine—Dysgeusia—Capecitabine—kidney cancer	4.91e-05	0.000273	CcSEcCtD
Clomipramine—Dizziness—Sunitinib—kidney cancer	4.91e-05	0.000273	CcSEcCtD
Clomipramine—Feeling abnormal—Gemcitabine—kidney cancer	4.91e-05	0.000273	CcSEcCtD
Clomipramine—Shock—Paclitaxel—kidney cancer	4.91e-05	0.000273	CcSEcCtD
Clomipramine—Vomiting—Sorafenib—kidney cancer	4.91e-05	0.000273	CcSEcCtD
Clomipramine—Orthostatic hypotension—Doxorubicin—kidney cancer	4.9e-05	0.000272	CcSEcCtD
Clomipramine—Nervous system disorder—Paclitaxel—kidney cancer	4.89e-05	0.000272	CcSEcCtD
Clomipramine—Hypokalaemia—Doxorubicin—kidney cancer	4.89e-05	0.000271	CcSEcCtD
Clomipramine—Thrombocytopenia—Paclitaxel—kidney cancer	4.89e-05	0.000271	CcSEcCtD
Clomipramine—Tachycardia—Paclitaxel—kidney cancer	4.87e-05	0.000271	CcSEcCtD
Clomipramine—Rash—Sorafenib—kidney cancer	4.87e-05	0.00027	CcSEcCtD
Clomipramine—Dermatitis—Sorafenib—kidney cancer	4.86e-05	0.00027	CcSEcCtD
Clomipramine—Back pain—Capecitabine—kidney cancer	4.85e-05	0.00027	CcSEcCtD
Clomipramine—Breast disorder—Doxorubicin—kidney cancer	4.85e-05	0.00027	CcSEcCtD
Clomipramine—Skin disorder—Paclitaxel—kidney cancer	4.85e-05	0.000269	CcSEcCtD
Clomipramine—Headache—Sorafenib—kidney cancer	4.84e-05	0.000269	CcSEcCtD
Clomipramine—Muscle spasms—Capecitabine—kidney cancer	4.82e-05	0.000268	CcSEcCtD
Clomipramine—Hyperhidrosis—Paclitaxel—kidney cancer	4.82e-05	0.000268	CcSEcCtD
Clomipramine—Diarrhoea—Dactinomycin—kidney cancer	4.81e-05	0.000267	CcSEcCtD
Clomipramine—Anorexia—Paclitaxel—kidney cancer	4.76e-05	0.000264	CcSEcCtD
Clomipramine—Gastritis—Doxorubicin—kidney cancer	4.75e-05	0.000264	CcSEcCtD
Clomipramine—Muscular weakness—Doxorubicin—kidney cancer	4.74e-05	0.000263	CcSEcCtD
Clomipramine—Vision blurred—Capecitabine—kidney cancer	4.73e-05	0.000263	CcSEcCtD
Clomipramine—Vomiting—Sunitinib—kidney cancer	4.72e-05	0.000262	CcSEcCtD
Clomipramine—Body temperature increased—Gemcitabine—kidney cancer	4.71e-05	0.000262	CcSEcCtD
Clomipramine—Tremor—Capecitabine—kidney cancer	4.7e-05	0.000261	CcSEcCtD
Clomipramine—Rash—Sunitinib—kidney cancer	4.68e-05	0.00026	CcSEcCtD
Clomipramine—Dermatitis—Sunitinib—kidney cancer	4.68e-05	0.00026	CcSEcCtD
Clomipramine—Hypotension—Paclitaxel—kidney cancer	4.66e-05	0.000259	CcSEcCtD
Clomipramine—Ill-defined disorder—Capecitabine—kidney cancer	4.65e-05	0.000259	CcSEcCtD
Clomipramine—Headache—Sunitinib—kidney cancer	4.65e-05	0.000258	CcSEcCtD
Clomipramine—Dysphagia—Doxorubicin—kidney cancer	4.64e-05	0.000258	CcSEcCtD
Clomipramine—Anaemia—Capecitabine—kidney cancer	4.64e-05	0.000258	CcSEcCtD
Clomipramine—Hypersensitivity—Vincristine—kidney cancer	4.63e-05	0.000257	CcSEcCtD
Clomipramine—Eosinophilia—Doxorubicin—kidney cancer	4.6e-05	0.000255	CcSEcCtD
Clomipramine—Nausea—Sorafenib—kidney cancer	4.58e-05	0.000255	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	4.55e-05	0.000253	CcSEcCtD
Clomipramine—Malaise—Capecitabine—kidney cancer	4.52e-05	0.000251	CcSEcCtD
Clomipramine—Insomnia—Paclitaxel—kidney cancer	4.51e-05	0.000251	CcSEcCtD
Clomipramine—Vertigo—Capecitabine—kidney cancer	4.51e-05	0.00025	CcSEcCtD
Clomipramine—Asthenia—Vincristine—kidney cancer	4.51e-05	0.00025	CcSEcCtD
Clomipramine—Syncope—Capecitabine—kidney cancer	4.5e-05	0.00025	CcSEcCtD
Clomipramine—Leukopenia—Capecitabine—kidney cancer	4.49e-05	0.000249	CcSEcCtD
Clomipramine—Paraesthesia—Paclitaxel—kidney cancer	4.48e-05	0.000249	CcSEcCtD
Clomipramine—Vomiting—Dactinomycin—kidney cancer	4.47e-05	0.000248	CcSEcCtD
Clomipramine—Bronchitis—Doxorubicin—kidney cancer	4.46e-05	0.000248	CcSEcCtD
Clomipramine—Dyspnoea—Paclitaxel—kidney cancer	4.45e-05	0.000247	CcSEcCtD
Clomipramine—Somnolence—Paclitaxel—kidney cancer	4.44e-05	0.000246	CcSEcCtD
Clomipramine—Palpitations—Capecitabine—kidney cancer	4.43e-05	0.000246	CcSEcCtD
Clomipramine—Rash—Dactinomycin—kidney cancer	4.43e-05	0.000246	CcSEcCtD
Clomipramine—Nausea—Sunitinib—kidney cancer	4.41e-05	0.000245	CcSEcCtD
Clomipramine—Loss of consciousness—Capecitabine—kidney cancer	4.41e-05	0.000245	CcSEcCtD
Clomipramine—Pancytopenia—Doxorubicin—kidney cancer	4.41e-05	0.000245	CcSEcCtD
Clomipramine—Dyspepsia—Paclitaxel—kidney cancer	4.39e-05	0.000244	CcSEcCtD
Clomipramine—Cough—Capecitabine—kidney cancer	4.38e-05	0.000243	CcSEcCtD
Clomipramine—Dysuria—Doxorubicin—kidney cancer	4.34e-05	0.000241	CcSEcCtD
Clomipramine—Decreased appetite—Paclitaxel—kidney cancer	4.34e-05	0.000241	CcSEcCtD
Clomipramine—Hypertension—Capecitabine—kidney cancer	4.33e-05	0.000241	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Paclitaxel—kidney cancer	4.31e-05	0.000239	CcSEcCtD
Clomipramine—Fatigue—Paclitaxel—kidney cancer	4.3e-05	0.000239	CcSEcCtD
Clomipramine—Diarrhoea—Vincristine—kidney cancer	4.3e-05	0.000239	CcSEcCtD
Clomipramine—Pollakiuria—Doxorubicin—kidney cancer	4.29e-05	0.000238	CcSEcCtD
Clomipramine—Asthenia—Gemcitabine—kidney cancer	4.28e-05	0.000238	CcSEcCtD
Clomipramine—Arthralgia—Capecitabine—kidney cancer	4.27e-05	0.000237	CcSEcCtD
Clomipramine—Chest pain—Capecitabine—kidney cancer	4.27e-05	0.000237	CcSEcCtD
Clomipramine—Myalgia—Capecitabine—kidney cancer	4.27e-05	0.000237	CcSEcCtD
Clomipramine—Constipation—Paclitaxel—kidney cancer	4.27e-05	0.000237	CcSEcCtD
Clomipramine—Pain—Paclitaxel—kidney cancer	4.27e-05	0.000237	CcSEcCtD
Clomipramine—Anxiety—Capecitabine—kidney cancer	4.26e-05	0.000236	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	4.24e-05	0.000236	CcSEcCtD
Clomipramine—Photosensitivity reaction—Doxorubicin—kidney cancer	4.24e-05	0.000235	CcSEcCtD
Clomipramine—Weight increased—Doxorubicin—kidney cancer	4.22e-05	0.000235	CcSEcCtD
Clomipramine—Discomfort—Capecitabine—kidney cancer	4.22e-05	0.000234	CcSEcCtD
Clomipramine—Pruritus—Gemcitabine—kidney cancer	4.22e-05	0.000234	CcSEcCtD
Clomipramine—Chlorprothixene—ABCB1—kidney cancer	4.21e-05	0.0123	CrCbGaD
Clomipramine—Weight decreased—Doxorubicin—kidney cancer	4.2e-05	0.000233	CcSEcCtD
Clomipramine—Hyperglycaemia—Doxorubicin—kidney cancer	4.19e-05	0.000233	CcSEcCtD
Clomipramine—Dry mouth—Capecitabine—kidney cancer	4.18e-05	0.000232	CcSEcCtD
Clomipramine—Nausea—Dactinomycin—kidney cancer	4.18e-05	0.000232	CcSEcCtD
Clomipramine—Pneumonia—Doxorubicin—kidney cancer	4.16e-05	0.000231	CcSEcCtD
Clomipramine—Dizziness—Vincristine—kidney cancer	4.15e-05	0.000231	CcSEcCtD
Clomipramine—Drowsiness—Doxorubicin—kidney cancer	4.14e-05	0.00023	CcSEcCtD
Clomipramine—Confusional state—Capecitabine—kidney cancer	4.13e-05	0.000229	CcSEcCtD
Clomipramine—Feeling abnormal—Paclitaxel—kidney cancer	4.11e-05	0.000228	CcSEcCtD
Clomipramine—Oedema—Capecitabine—kidney cancer	4.09e-05	0.000227	CcSEcCtD
Clomipramine—Gastrointestinal pain—Paclitaxel—kidney cancer	4.08e-05	0.000227	CcSEcCtD
Clomipramine—Diarrhoea—Gemcitabine—kidney cancer	4.08e-05	0.000227	CcSEcCtD
Clomipramine—Neuropathy peripheral—Doxorubicin—kidney cancer	4.06e-05	0.000225	CcSEcCtD
Clomipramine—Jaundice—Doxorubicin—kidney cancer	4.03e-05	0.000224	CcSEcCtD
Clomipramine—Shock—Capecitabine—kidney cancer	4.03e-05	0.000224	CcSEcCtD
Clomipramine—Conjunctivitis—Doxorubicin—kidney cancer	4.02e-05	0.000223	CcSEcCtD
Clomipramine—Urinary tract infection—Doxorubicin—kidney cancer	4.02e-05	0.000223	CcSEcCtD
Clomipramine—Nervous system disorder—Capecitabine—kidney cancer	4.02e-05	0.000223	CcSEcCtD
Clomipramine—Thrombocytopenia—Capecitabine—kidney cancer	4.01e-05	0.000223	CcSEcCtD
Clomipramine—Tachycardia—Capecitabine—kidney cancer	4e-05	0.000222	CcSEcCtD
Clomipramine—Vomiting—Vincristine—kidney cancer	3.99e-05	0.000222	CcSEcCtD
Clomipramine—Skin disorder—Capecitabine—kidney cancer	3.98e-05	0.000221	CcSEcCtD
Clomipramine—Sweating—Doxorubicin—kidney cancer	3.97e-05	0.00022	CcSEcCtD
Clomipramine—Urticaria—Paclitaxel—kidney cancer	3.96e-05	0.00022	CcSEcCtD
Clomipramine—Rash—Vincristine—kidney cancer	3.96e-05	0.00022	CcSEcCtD
Clomipramine—Hyperhidrosis—Capecitabine—kidney cancer	3.96e-05	0.00022	CcSEcCtD
Clomipramine—Dermatitis—Vincristine—kidney cancer	3.96e-05	0.00022	CcSEcCtD
Clomipramine—Haematuria—Doxorubicin—kidney cancer	3.95e-05	0.000219	CcSEcCtD
Clomipramine—Body temperature increased—Paclitaxel—kidney cancer	3.94e-05	0.000219	CcSEcCtD
Clomipramine—Abdominal pain—Paclitaxel—kidney cancer	3.94e-05	0.000219	CcSEcCtD
Clomipramine—Headache—Vincristine—kidney cancer	3.94e-05	0.000219	CcSEcCtD
Clomipramine—Flurazepam—ABCB1—kidney cancer	3.93e-05	0.0115	CrCbGaD
Clomipramine—Hepatobiliary disease—Doxorubicin—kidney cancer	3.91e-05	0.000217	CcSEcCtD
Clomipramine—Epistaxis—Doxorubicin—kidney cancer	3.9e-05	0.000217	CcSEcCtD
Clomipramine—Anorexia—Capecitabine—kidney cancer	3.9e-05	0.000217	CcSEcCtD
Clomipramine—Trimipramine—ABCB1—kidney cancer	3.89e-05	0.0113	CrCbGaD
Clomipramine—Sinusitis—Doxorubicin—kidney cancer	3.88e-05	0.000216	CcSEcCtD
Clomipramine—Agranulocytosis—Doxorubicin—kidney cancer	3.86e-05	0.000215	CcSEcCtD
Clomipramine—Hypotension—Capecitabine—kidney cancer	3.83e-05	0.000213	CcSEcCtD
Clomipramine—Vomiting—Gemcitabine—kidney cancer	3.79e-05	0.00021	CcSEcCtD
Clomipramine—Bradycardia—Doxorubicin—kidney cancer	3.78e-05	0.00021	CcSEcCtD
Clomipramine—Rash—Gemcitabine—kidney cancer	3.76e-05	0.000209	CcSEcCtD
Clomipramine—Dermatitis—Gemcitabine—kidney cancer	3.75e-05	0.000209	CcSEcCtD
Clomipramine—Promethazine—ABCB1—kidney cancer	3.75e-05	0.0109	CrCbGaD
Clomipramine—Headache—Gemcitabine—kidney cancer	3.73e-05	0.000207	CcSEcCtD
Clomipramine—Nausea—Vincristine—kidney cancer	3.73e-05	0.000207	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Capecitabine—kidney cancer	3.73e-05	0.000207	CcSEcCtD
Clomipramine—Rhinitis—Doxorubicin—kidney cancer	3.72e-05	0.000207	CcSEcCtD
Clomipramine—Hepatitis—Doxorubicin—kidney cancer	3.71e-05	0.000206	CcSEcCtD
Clomipramine—Doxepin—ABCB1—kidney cancer	3.71e-05	0.0108	CrCbGaD
Clomipramine—Insomnia—Capecitabine—kidney cancer	3.7e-05	0.000206	CcSEcCtD
Clomipramine—Trifluoperazine—ABCB1—kidney cancer	3.7e-05	0.0108	CrCbGaD
Clomipramine—Hypoaesthesia—Doxorubicin—kidney cancer	3.7e-05	0.000205	CcSEcCtD
Clomipramine—Pharyngitis—Doxorubicin—kidney cancer	3.69e-05	0.000205	CcSEcCtD
Clomipramine—Paraesthesia—Capecitabine—kidney cancer	3.68e-05	0.000204	CcSEcCtD
Clomipramine—Hypersensitivity—Paclitaxel—kidney cancer	3.68e-05	0.000204	CcSEcCtD
Clomipramine—Urinary tract disorder—Doxorubicin—kidney cancer	3.67e-05	0.000204	CcSEcCtD
Clomipramine—Connective tissue disorder—Doxorubicin—kidney cancer	3.65e-05	0.000203	CcSEcCtD
Clomipramine—Dyspnoea—Capecitabine—kidney cancer	3.65e-05	0.000203	CcSEcCtD
Clomipramine—Urethral disorder—Doxorubicin—kidney cancer	3.64e-05	0.000202	CcSEcCtD
Clomipramine—Dyspepsia—Capecitabine—kidney cancer	3.6e-05	0.0002	CcSEcCtD
Clomipramine—Visual impairment—Doxorubicin—kidney cancer	3.58e-05	0.000199	CcSEcCtD
Clomipramine—Asthenia—Paclitaxel—kidney cancer	3.58e-05	0.000199	CcSEcCtD
Clomipramine—Decreased appetite—Capecitabine—kidney cancer	3.56e-05	0.000198	CcSEcCtD
Clomipramine—Nausea—Gemcitabine—kidney cancer	3.54e-05	0.000197	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Capecitabine—kidney cancer	3.53e-05	0.000196	CcSEcCtD
Clomipramine—Fatigue—Capecitabine—kidney cancer	3.53e-05	0.000196	CcSEcCtD
Clomipramine—Pruritus—Paclitaxel—kidney cancer	3.53e-05	0.000196	CcSEcCtD
Clomipramine—Pain—Capecitabine—kidney cancer	3.5e-05	0.000195	CcSEcCtD
Clomipramine—Constipation—Capecitabine—kidney cancer	3.5e-05	0.000195	CcSEcCtD
Clomipramine—Eye disorder—Doxorubicin—kidney cancer	3.47e-05	0.000193	CcSEcCtD
Clomipramine—Tinnitus—Doxorubicin—kidney cancer	3.46e-05	0.000192	CcSEcCtD
Clomipramine—Cardiac disorder—Doxorubicin—kidney cancer	3.45e-05	0.000192	CcSEcCtD
Clomipramine—Flushing—Doxorubicin—kidney cancer	3.45e-05	0.000192	CcSEcCtD
Clomipramine—Diarrhoea—Paclitaxel—kidney cancer	3.41e-05	0.00019	CcSEcCtD
Clomipramine—Desipramine—ABCB1—kidney cancer	3.4e-05	0.00992	CrCbGaD
Clomipramine—Feeling abnormal—Capecitabine—kidney cancer	3.37e-05	0.000187	CcSEcCtD
Clomipramine—Angiopathy—Doxorubicin—kidney cancer	3.37e-05	0.000187	CcSEcCtD
Clomipramine—Immune system disorder—Doxorubicin—kidney cancer	3.36e-05	0.000186	CcSEcCtD
Clomipramine—Gastrointestinal pain—Capecitabine—kidney cancer	3.35e-05	0.000186	CcSEcCtD
Clomipramine—Mediastinal disorder—Doxorubicin—kidney cancer	3.35e-05	0.000186	CcSEcCtD
Clomipramine—Chills—Doxorubicin—kidney cancer	3.33e-05	0.000185	CcSEcCtD
Clomipramine—Arrhythmia—Doxorubicin—kidney cancer	3.32e-05	0.000184	CcSEcCtD
Clomipramine—Dizziness—Paclitaxel—kidney cancer	3.3e-05	0.000183	CcSEcCtD
Clomipramine—Alopecia—Doxorubicin—kidney cancer	3.28e-05	0.000182	CcSEcCtD
Clomipramine—Mental disorder—Doxorubicin—kidney cancer	3.25e-05	0.000181	CcSEcCtD
Clomipramine—Urticaria—Capecitabine—kidney cancer	3.25e-05	0.000181	CcSEcCtD
Clomipramine—Body temperature increased—Capecitabine—kidney cancer	3.24e-05	0.00018	CcSEcCtD
Clomipramine—Abdominal pain—Capecitabine—kidney cancer	3.24e-05	0.00018	CcSEcCtD
Clomipramine—Malnutrition—Doxorubicin—kidney cancer	3.23e-05	0.00018	CcSEcCtD
Clomipramine—Flatulence—Doxorubicin—kidney cancer	3.19e-05	0.000177	CcSEcCtD
Clomipramine—Tension—Doxorubicin—kidney cancer	3.17e-05	0.000176	CcSEcCtD
Clomipramine—Vomiting—Paclitaxel—kidney cancer	3.17e-05	0.000176	CcSEcCtD
Clomipramine—Dysgeusia—Doxorubicin—kidney cancer	3.17e-05	0.000176	CcSEcCtD
Clomipramine—Rash—Paclitaxel—kidney cancer	3.15e-05	0.000175	CcSEcCtD
Clomipramine—Dermatitis—Paclitaxel—kidney cancer	3.14e-05	0.000175	CcSEcCtD
Clomipramine—Nervousness—Doxorubicin—kidney cancer	3.14e-05	0.000174	CcSEcCtD
Clomipramine—Back pain—Doxorubicin—kidney cancer	3.13e-05	0.000174	CcSEcCtD
Clomipramine—Headache—Paclitaxel—kidney cancer	3.13e-05	0.000174	CcSEcCtD
Clomipramine—Diazepam—ABCB1—kidney cancer	3.13e-05	0.00911	CrCbGaD
Clomipramine—Muscle spasms—Doxorubicin—kidney cancer	3.11e-05	0.000173	CcSEcCtD
Clomipramine—Vision blurred—Doxorubicin—kidney cancer	3.05e-05	0.000169	CcSEcCtD
Clomipramine—Hypersensitivity—Capecitabine—kidney cancer	3.02e-05	0.000168	CcSEcCtD
Clomipramine—Ill-defined disorder—Doxorubicin—kidney cancer	3e-05	0.000167	CcSEcCtD
Clomipramine—Anaemia—Doxorubicin—kidney cancer	2.99e-05	0.000166	CcSEcCtD
Clomipramine—Agitation—Doxorubicin—kidney cancer	2.97e-05	0.000165	CcSEcCtD
Clomipramine—Nausea—Paclitaxel—kidney cancer	2.96e-05	0.000165	CcSEcCtD
Clomipramine—Asthenia—Capecitabine—kidney cancer	2.94e-05	0.000163	CcSEcCtD
Clomipramine—Malaise—Doxorubicin—kidney cancer	2.92e-05	0.000162	CcSEcCtD
Clomipramine—Vertigo—Doxorubicin—kidney cancer	2.91e-05	0.000161	CcSEcCtD
Clomipramine—Chlorpromazine—ABCB1—kidney cancer	2.9e-05	0.00846	CrCbGaD
Clomipramine—Syncope—Doxorubicin—kidney cancer	2.9e-05	0.000161	CcSEcCtD
Clomipramine—Pruritus—Capecitabine—kidney cancer	2.9e-05	0.000161	CcSEcCtD
Clomipramine—Leukopenia—Doxorubicin—kidney cancer	2.89e-05	0.000161	CcSEcCtD
Clomipramine—Imipramine—ABCB1—kidney cancer	2.89e-05	0.00842	CrCbGaD
Clomipramine—Amitriptyline—ABCB1—kidney cancer	2.87e-05	0.00836	CrCbGaD
Clomipramine—Palpitations—Doxorubicin—kidney cancer	2.86e-05	0.000159	CcSEcCtD
Clomipramine—Loss of consciousness—Doxorubicin—kidney cancer	2.84e-05	0.000158	CcSEcCtD
Clomipramine—Cough—Doxorubicin—kidney cancer	2.82e-05	0.000157	CcSEcCtD
Clomipramine—Convulsion—Doxorubicin—kidney cancer	2.8e-05	0.000156	CcSEcCtD
Clomipramine—Diarrhoea—Capecitabine—kidney cancer	2.8e-05	0.000156	CcSEcCtD
Clomipramine—Hypertension—Doxorubicin—kidney cancer	2.79e-05	0.000155	CcSEcCtD
Clomipramine—Chest pain—Doxorubicin—kidney cancer	2.75e-05	0.000153	CcSEcCtD
Clomipramine—Myalgia—Doxorubicin—kidney cancer	2.75e-05	0.000153	CcSEcCtD
Clomipramine—Arthralgia—Doxorubicin—kidney cancer	2.75e-05	0.000153	CcSEcCtD
Clomipramine—Anxiety—Doxorubicin—kidney cancer	2.74e-05	0.000152	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	2.73e-05	0.000152	CcSEcCtD
Clomipramine—Discomfort—Doxorubicin—kidney cancer	2.72e-05	0.000151	CcSEcCtD
Clomipramine—Dizziness—Capecitabine—kidney cancer	2.71e-05	0.00015	CcSEcCtD
Clomipramine—Dry mouth—Doxorubicin—kidney cancer	2.69e-05	0.00015	CcSEcCtD
Clomipramine—Confusional state—Doxorubicin—kidney cancer	2.66e-05	0.000148	CcSEcCtD
Clomipramine—Oedema—Doxorubicin—kidney cancer	2.64e-05	0.000147	CcSEcCtD
Clomipramine—Anaphylactic shock—Doxorubicin—kidney cancer	2.64e-05	0.000147	CcSEcCtD
Clomipramine—Vomiting—Capecitabine—kidney cancer	2.6e-05	0.000145	CcSEcCtD
Clomipramine—Shock—Doxorubicin—kidney cancer	2.6e-05	0.000144	CcSEcCtD
Clomipramine—Nervous system disorder—Doxorubicin—kidney cancer	2.59e-05	0.000144	CcSEcCtD
Clomipramine—Thrombocytopenia—Doxorubicin—kidney cancer	2.58e-05	0.000144	CcSEcCtD
Clomipramine—Rash—Capecitabine—kidney cancer	2.58e-05	0.000143	CcSEcCtD
Clomipramine—Dermatitis—Capecitabine—kidney cancer	2.58e-05	0.000143	CcSEcCtD
Clomipramine—Tachycardia—Doxorubicin—kidney cancer	2.58e-05	0.000143	CcSEcCtD
Clomipramine—Headache—Capecitabine—kidney cancer	2.57e-05	0.000142	CcSEcCtD
Clomipramine—Skin disorder—Doxorubicin—kidney cancer	2.56e-05	0.000142	CcSEcCtD
Clomipramine—Hyperhidrosis—Doxorubicin—kidney cancer	2.55e-05	0.000142	CcSEcCtD
Clomipramine—Anorexia—Doxorubicin—kidney cancer	2.52e-05	0.00014	CcSEcCtD
Clomipramine—Hypotension—Doxorubicin—kidney cancer	2.47e-05	0.000137	CcSEcCtD
Clomipramine—Nausea—Capecitabine—kidney cancer	2.43e-05	0.000135	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	2.4e-05	0.000134	CcSEcCtD
Clomipramine—Insomnia—Doxorubicin—kidney cancer	2.39e-05	0.000133	CcSEcCtD
Clomipramine—Paraesthesia—Doxorubicin—kidney cancer	2.37e-05	0.000132	CcSEcCtD
Clomipramine—Dyspnoea—Doxorubicin—kidney cancer	2.35e-05	0.000131	CcSEcCtD
Clomipramine—Somnolence—Doxorubicin—kidney cancer	2.35e-05	0.00013	CcSEcCtD
Clomipramine—Dyspepsia—Doxorubicin—kidney cancer	2.32e-05	0.000129	CcSEcCtD
Clomipramine—Decreased appetite—Doxorubicin—kidney cancer	2.29e-05	0.000127	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.28e-05	0.000127	CcSEcCtD
Clomipramine—Fatigue—Doxorubicin—kidney cancer	2.28e-05	0.000126	CcSEcCtD
Clomipramine—Constipation—Doxorubicin—kidney cancer	2.26e-05	0.000125	CcSEcCtD
Clomipramine—Pain—Doxorubicin—kidney cancer	2.26e-05	0.000125	CcSEcCtD
Clomipramine—Feeling abnormal—Doxorubicin—kidney cancer	2.17e-05	0.000121	CcSEcCtD
Clomipramine—Gastrointestinal pain—Doxorubicin—kidney cancer	2.16e-05	0.00012	CcSEcCtD
Clomipramine—Urticaria—Doxorubicin—kidney cancer	2.1e-05	0.000116	CcSEcCtD
Clomipramine—Abdominal pain—Doxorubicin—kidney cancer	2.09e-05	0.000116	CcSEcCtD
Clomipramine—Body temperature increased—Doxorubicin—kidney cancer	2.09e-05	0.000116	CcSEcCtD
Clomipramine—Hypersensitivity—Doxorubicin—kidney cancer	1.94e-05	0.000108	CcSEcCtD
Clomipramine—Asthenia—Doxorubicin—kidney cancer	1.89e-05	0.000105	CcSEcCtD
Clomipramine—Pruritus—Doxorubicin—kidney cancer	1.87e-05	0.000104	CcSEcCtD
Clomipramine—Diarrhoea—Doxorubicin—kidney cancer	1.81e-05	0.0001	CcSEcCtD
Clomipramine—Dizziness—Doxorubicin—kidney cancer	1.75e-05	9.7e-05	CcSEcCtD
Clomipramine—Vomiting—Doxorubicin—kidney cancer	1.68e-05	9.32e-05	CcSEcCtD
Clomipramine—Rash—Doxorubicin—kidney cancer	1.66e-05	9.24e-05	CcSEcCtD
Clomipramine—Dermatitis—Doxorubicin—kidney cancer	1.66e-05	9.24e-05	CcSEcCtD
Clomipramine—Headache—Doxorubicin—kidney cancer	1.65e-05	9.18e-05	CcSEcCtD
Clomipramine—Nausea—Doxorubicin—kidney cancer	1.57e-05	8.71e-05	CcSEcCtD
Clomipramine—CYP1A2—Metabolism—ITPR2—kidney cancer	4.8e-06	0.000143	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CYP1A1—kidney cancer	4.79e-06	0.000142	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—BCHE—kidney cancer	4.78e-06	0.000142	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CTNNB1—kidney cancer	4.77e-06	0.000142	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IGF1R—kidney cancer	4.75e-06	0.000141	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PSMD7—kidney cancer	4.75e-06	0.000141	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—IL2—kidney cancer	4.73e-06	0.000141	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—SLC5A5—kidney cancer	4.72e-06	0.00014	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—MAPK3—kidney cancer	4.71e-06	0.00014	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—KRAS—kidney cancer	4.7e-06	0.00014	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—PIK3CA—kidney cancer	4.69e-06	0.000139	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CA9—kidney cancer	4.69e-06	0.000139	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—POMC—kidney cancer	4.68e-06	0.000139	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—SLC2A1—kidney cancer	4.67e-06	0.000139	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—PTEN—kidney cancer	4.65e-06	0.000138	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—KRAS—kidney cancer	4.64e-06	0.000138	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—BRAF—kidney cancer	4.62e-06	0.000137	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—RAF1—kidney cancer	4.58e-06	0.000136	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—SLC2A1—kidney cancer	4.56e-06	0.000135	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.53e-06	0.000135	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—IL2—kidney cancer	4.52e-06	0.000134	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HIF1A—kidney cancer	4.51e-06	0.000134	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—BCHE—kidney cancer	4.5e-06	0.000134	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TSC2—kidney cancer	4.49e-06	0.000134	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—MAPK1—kidney cancer	4.48e-06	0.000133	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IGF2—kidney cancer	4.47e-06	0.000133	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CDKN2B—kidney cancer	4.45e-06	0.000132	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—SLC5A5—kidney cancer	4.45e-06	0.000132	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.43e-06	0.000132	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.4e-06	0.000131	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GSTT1—kidney cancer	4.38e-06	0.00013	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ACHE—kidney cancer	4.38e-06	0.00013	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—VEGFA—kidney cancer	4.37e-06	0.00013	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	4.35e-06	0.000129	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GSTP1—kidney cancer	4.34e-06	0.000129	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IGF1R—kidney cancer	4.32e-06	0.000129	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—PIK3CA—kidney cancer	4.32e-06	0.000128	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—KDR—kidney cancer	4.31e-06	0.000128	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—SLC2A1—kidney cancer	4.29e-06	0.000128	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—PIK3CA—kidney cancer	4.28e-06	0.000127	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—PIK3CA—kidney cancer	4.26e-06	0.000127	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—KRAS—kidney cancer	4.23e-06	0.000126	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—RAF1—kidney cancer	4.23e-06	0.000126	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—RELA—kidney cancer	4.21e-06	0.000125	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—VEGFA—kidney cancer	4.2e-06	0.000125	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—ERBB2—kidney cancer	4.19e-06	0.000124	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—TP53—kidney cancer	4.18e-06	0.000124	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—RAF1—kidney cancer	4.17e-06	0.000124	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—SCARB1—kidney cancer	4.14e-06	0.000123	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MTOR—kidney cancer	4.13e-06	0.000123	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—MAPK3—kidney cancer	4.13e-06	0.000123	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—IL2—kidney cancer	4.11e-06	0.000122	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—IL2—kidney cancer	4.11e-06	0.000122	CbGpPWpGaD
Clomipramine—ALB—Metabolism—ABCB1—kidney cancer	4.11e-06	0.000122	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTGS1—kidney cancer	4.1e-06	0.000122	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PSMD7—kidney cancer	4.02e-06	0.00012	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GSTM1—kidney cancer	3.99e-06	0.000118	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CRABP1—kidney cancer	3.98e-06	0.000118	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MAPK3—kidney cancer	3.98e-06	0.000118	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—APC—kidney cancer	3.97e-06	0.000118	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—KIT—kidney cancer	3.97e-06	0.000118	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.95e-06	0.000117	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—MAPK1—kidney cancer	3.93e-06	0.000117	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HIF1A—kidney cancer	3.91e-06	0.000116	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TSC2—kidney cancer	3.9e-06	0.000116	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GSTP1—kidney cancer	3.89e-06	0.000116	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—PIK3CA—kidney cancer	3.89e-06	0.000116	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CDKN1B—kidney cancer	3.88e-06	0.000115	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MYC—kidney cancer	3.87e-06	0.000115	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—RAF1—kidney cancer	3.86e-06	0.000115	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—RELA—kidney cancer	3.84e-06	0.000114	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—ERBB2—kidney cancer	3.82e-06	0.000114	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—BCHE—kidney cancer	3.81e-06	0.000113	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—MAPK3—kidney cancer	3.8e-06	0.000113	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GSTP1—kidney cancer	3.8e-06	0.000113	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IL2—kidney cancer	3.79e-06	0.000113	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MAPK1—kidney cancer	3.78e-06	0.000112	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CYP1A1—kidney cancer	3.78e-06	0.000112	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—POMC—kidney cancer	3.78e-06	0.000112	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MTOR—kidney cancer	3.77e-06	0.000112	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—SLC5A5—kidney cancer	3.77e-06	0.000112	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—KDR—kidney cancer	3.74e-06	0.000111	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—IL2—kidney cancer	3.74e-06	0.000111	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—BRAF—kidney cancer	3.73e-06	0.000111	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—KRAS—kidney cancer	3.71e-06	0.00011	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ITPR2—kidney cancer	3.7e-06	0.00011	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CCND1—kidney cancer	3.7e-06	0.00011	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—JUN—kidney cancer	3.69e-06	0.00011	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ABCB1—kidney cancer	3.69e-06	0.00011	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CTNNB1—kidney cancer	3.66e-06	0.000109	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—SLC2A1—kidney cancer	3.64e-06	0.000108	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—MAPK1—kidney cancer	3.62e-06	0.000107	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GSTP1—kidney cancer	3.58e-06	0.000106	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GSTM1—kidney cancer	3.58e-06	0.000106	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—KRAS—kidney cancer	3.57e-06	0.000106	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—POMC—kidney cancer	3.57e-06	0.000106	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PTEN—kidney cancer	3.57e-06	0.000106	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HIF1A—kidney cancer	3.56e-06	0.000106	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TSC2—kidney cancer	3.55e-06	0.000106	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CDKN1B—kidney cancer	3.54e-06	0.000105	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.53e-06	0.000105	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GSTM1—kidney cancer	3.49e-06	0.000104	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL2—kidney cancer	3.46e-06	0.000103	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—PIK3CA—kidney cancer	3.46e-06	0.000103	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—APC—kidney cancer	3.45e-06	0.000102	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—KIT—kidney cancer	3.45e-06	0.000102	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—KRAS—kidney cancer	3.42e-06	0.000102	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—PIK3CA—kidney cancer	3.41e-06	0.000101	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—KDR—kidney cancer	3.4e-06	0.000101	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CYP1A1—kidney cancer	3.39e-06	0.000101	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ABCB1—kidney cancer	3.39e-06	0.000101	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ACHE—kidney cancer	3.38e-06	0.0001	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GSTT1—kidney cancer	3.38e-06	0.0001	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CCND1—kidney cancer	3.38e-06	0.0001	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—JUN—kidney cancer	3.37e-06	0.0001	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CTNNB1—kidney cancer	3.34e-06	9.93e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CYP1A1—kidney cancer	3.31e-06	9.84e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—MAPK3—kidney cancer	3.3e-06	9.81e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—TP53—kidney cancer	3.3e-06	9.8e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GSTM1—kidney cancer	3.29e-06	9.78e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—PIK3CA—kidney cancer	3.28e-06	9.76e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—POMC—kidney cancer	3.28e-06	9.75e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PTEN—kidney cancer	3.26e-06	9.68e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—BRAF—kidney cancer	3.24e-06	9.63e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—VEGFA—kidney cancer	3.22e-06	9.58e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—SCARB1—kidney cancer	3.2e-06	9.5e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TP53—kidney cancer	3.18e-06	9.44e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTGS1—kidney cancer	3.17e-06	9.41e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—MAPK1—kidney cancer	3.14e-06	9.34e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—PIK3CA—kidney cancer	3.14e-06	9.33e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—KIT—kidney cancer	3.14e-06	9.32e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—APC—kidney cancer	3.14e-06	9.32e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CYP1A1—kidney cancer	3.12e-06	9.27e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—RAF1—kidney cancer	3.12e-06	9.26e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.1e-06	9.23e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PSMD7—kidney cancer	3.1e-06	9.23e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—RELA—kidney cancer	3.1e-06	9.22e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—ERBB2—kidney cancer	3.08e-06	9.16e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.08e-06	9.15e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MAPK3—kidney cancer	3.05e-06	9.06e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MTOR—kidney cancer	3.04e-06	9.04e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GSTP1—kidney cancer	3.03e-06	9.02e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—MAPK3—kidney cancer	3e-06	8.93e-05	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—PIK3CA—kidney cancer	3e-06	8.92e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—POMC—kidney cancer	2.99e-06	8.87e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—KRAS—kidney cancer	2.97e-06	8.82e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MYC—kidney cancer	2.97e-06	8.81e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—BRAF—kidney cancer	2.95e-06	8.76e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—BCHE—kidney cancer	2.94e-06	8.75e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—VEGFA—kidney cancer	2.94e-06	8.75e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.91e-06	8.64e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MAPK1—kidney cancer	2.9e-06	8.62e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ABCB1—kidney cancer	2.87e-06	8.54e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—MAPK1—kidney cancer	2.86e-06	8.49e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CDKN1B—kidney cancer	2.85e-06	8.48e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PTGS2—kidney cancer	2.85e-06	8.46e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—POMC—kidney cancer	2.82e-06	8.37e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.81e-06	8.34e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL2—kidney cancer	2.79e-06	8.3e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GSTM1—kidney cancer	2.79e-06	8.29e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.79e-06	8.28e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MAPK3—kidney cancer	2.78e-06	8.27e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—KRAS—kidney cancer	2.74e-06	8.14e-05	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—PIK3CA—kidney cancer	2.73e-06	8.12e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—PIK3CA—kidney cancer	2.73e-06	8.1e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CCND1—kidney cancer	2.72e-06	8.09e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—JUN—kidney cancer	2.72e-06	8.08e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MYC—kidney cancer	2.71e-06	8.05e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—RAF1—kidney cancer	2.71e-06	8.04e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—KRAS—kidney cancer	2.7e-06	8.02e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CTNNB1—kidney cancer	2.7e-06	8.01e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—RELA—kidney cancer	2.69e-06	8e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ERBB2—kidney cancer	2.68e-06	7.95e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MAPK1—kidney cancer	2.65e-06	7.87e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYP1A1—kidney cancer	2.64e-06	7.86e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MTOR—kidney cancer	2.64e-06	7.85e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PTEN—kidney cancer	2.63e-06	7.81e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—POMC—kidney cancer	2.53e-06	7.52e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PIK3CA—kidney cancer	2.52e-06	7.48e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—KRAS—kidney cancer	2.5e-06	7.43e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PTEN—kidney cancer	2.48e-06	7.38e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—PIK3CA—kidney cancer	2.48e-06	7.37e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CDKN1B—kidney cancer	2.48e-06	7.37e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—POMC—kidney cancer	2.47e-06	7.34e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—RAF1—kidney cancer	2.46e-06	7.31e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—RELA—kidney cancer	2.45e-06	7.28e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TP53—kidney cancer	2.44e-06	7.24e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ERBB2—kidney cancer	2.44e-06	7.24e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL2—kidney cancer	2.43e-06	7.21e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MTOR—kidney cancer	2.4e-06	7.14e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—VEGFA—kidney cancer	2.37e-06	7.06e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCND1—kidney cancer	2.36e-06	7.03e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—JUN—kidney cancer	2.36e-06	7.01e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	2.34e-06	6.96e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GSTP1—kidney cancer	2.34e-06	6.96e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—POMC—kidney cancer	2.33e-06	6.91e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PIK3CA—kidney cancer	2.3e-06	6.83e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PTEN—kidney cancer	2.28e-06	6.78e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CDKN1B—kidney cancer	2.26e-06	6.7e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PTGS2—kidney cancer	2.25e-06	6.68e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MAPK3—kidney cancer	2.25e-06	6.67e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TP53—kidney cancer	2.22e-06	6.61e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ABCB1—kidney cancer	2.22e-06	6.59e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL2—kidney cancer	2.21e-06	6.56e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MYC—kidney cancer	2.18e-06	6.49e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.17e-06	6.45e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GSTM1—kidney cancer	2.15e-06	6.4e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCND1—kidney cancer	2.15e-06	6.39e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—JUN—kidney cancer	2.15e-06	6.38e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MAPK1—kidney cancer	2.14e-06	6.35e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CTNNB1—kidney cancer	2.13e-06	6.33e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PTEN—kidney cancer	2.08e-06	6.17e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—VEGFA—kidney cancer	2.06e-06	6.13e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.04e-06	6.06e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—KRAS—kidney cancer	2.02e-06	6e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PTGS2—kidney cancer	2.02e-06	6e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—POMC—kidney cancer	1.97e-06	5.86e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PTGS2—kidney cancer	1.97e-06	5.85e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PTEN—kidney cancer	1.96e-06	5.82e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MAPK3—kidney cancer	1.95e-06	5.8e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MYC—kidney cancer	1.9e-06	5.64e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—VEGFA—kidney cancer	1.88e-06	5.57e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MAPK1—kidney cancer	1.86e-06	5.51e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PTGS2—kidney cancer	1.86e-06	5.51e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PIK3CA—kidney cancer	1.85e-06	5.51e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TP53—kidney cancer	1.79e-06	5.33e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MAPK3—kidney cancer	1.77e-06	5.27e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PTEN—kidney cancer	1.76e-06	5.23e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—KRAS—kidney cancer	1.75e-06	5.21e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PIK3CA—kidney cancer	1.75e-06	5.21e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MYC—kidney cancer	1.73e-06	5.13e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PTEN—kidney cancer	1.72e-06	5.1e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MAPK1—kidney cancer	1.69e-06	5.02e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PTEN—kidney cancer	1.62e-06	4.81e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	1.61e-06	4.79e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—KRAS—kidney cancer	1.59e-06	4.74e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTGS2—kidney cancer	1.57e-06	4.67e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TP53—kidney cancer	1.56e-06	4.63e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—POMC—kidney cancer	1.52e-06	4.52e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PIK3CA—kidney cancer	1.46e-06	4.35e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TP53—kidney cancer	1.42e-06	4.21e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PIK3CA—kidney cancer	1.38e-06	4.11e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTEN—kidney cancer	1.37e-06	4.07e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.24e-06	3.69e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTGS2—kidney cancer	1.21e-06	3.61e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PIK3CA—kidney cancer	1.21e-06	3.6e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.14e-06	3.39e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTEN—kidney cancer	1.06e-06	3.14e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PIK3CA—kidney cancer	9.67e-07	2.87e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PIK3CA—kidney cancer	7.46e-07	2.22e-05	CbGpPWpGaD
